Novarex Capital Partners Maintains Allocation Standards Following International Investment Approach
Novarex Capital Partners has declined a proposal from a US-based entity seeking the company’s remainingavailable allocation, choosing instead to maintain its established investor assessment and allocationprocedures.
London, United Kingdom, 19th Aug 2026 – Novarex Capital Partners has announced that it has declined a proposal from a US-based entity seeking to acquire the company’s entire remaining available allocation following the completion of its initial £5 million funding round.
The approach was received following Novarex Capital Partners’ announcement of the successful completion of its initial funding milestone. Due to confidentiality obligations and existing non-disclosure agreements, the identity of the US-based entity cannot be disclosed.
While the proposal represented a signifi...
